Are multiple markers the future of prostate cancer diagnostics?

Clinical Biochemistry
Stephen D MikolajczykHarry G Rittenhouse

Abstract

Prostate specific antigen (PSA) is the most successful and widely employed cancer serum marker in use today. There is growing evidence that the introduction of wide PSA screening and earlier detection can result in decreased cancer mortality associated with a decline in metastatic disease. PSA circulates in a number of distinct forms. Measurement of these in addition to total PSA significantly increases diagnostic utility. Diagnostic utility is likely to be further increased by adding kallikreins, cytokines, growth factors, receptors and cellular adhesion factors to the biomarker panel. The need for multiple markers reflects the multidimensional nature of prostate disease which ranges from metastatic cancer to indolent cancer to benign hyperplasia and inflammation, all of which require distinct treatments and medical interventions.

References

Jan 1, 1989·Journal of Pharmaceutical and Biomedical Analysis·R P Ekins
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·M SchenaR W Davis
Dec 1, 1996·Nature Biotechnology·D J LockhartE L Brown
Jul 14, 1998·Nature Medicine·J KononenO P Kallioniemi
Oct 6, 1998·Critical Reviews in Clinical Laboratory Sciences·H G RittenhouseA W Partin
Jan 23, 1999·Nature Genetics·D J DugganJ M Trent
Jan 23, 1999·Nature Genetics·R J LipshutzD J Lockhart
Sep 15, 2000·Journal of Immunological Methods·D A Vignali
Aug 24, 2001·Nature·S M DhanasekaranA M Chinnaiyan
Mar 30, 2002·Nature Biotechnology·Barry SchweitzerStephen F Kingsmore
Apr 3, 2002·JAMA : the Journal of the American Medical Association·Mark A RubinArul M Chinnaiyan
Oct 11, 2002·Nature·Sooryanarayana VaramballyArul M Chinnaiyan
Jan 28, 2003·Drug Discovery Today·Oren E Beske, Simon Goldbard
Feb 1, 2003·Clinical Chemistry·Harry J LintonStephen D Mikolajczyk
Mar 11, 2003·Technology in Cancer Research & Treatment·Rene C KriegEmanuel F Petricoin
May 3, 2003·Cancer Cell·Lance A LiottaEmanuel F Petricoin
Jul 17, 2003·The Keio Journal of Medicine·Stephen D Mikolajczyk, Harry G Rittenhouse
Jul 25, 2003·The New England Journal of Medicine·Rinaa S PungliaKaren M Kuntz
Aug 23, 2003·Biostatistics·M S Pepe, M L Thompson
Oct 15, 2003·Biostatistics·Ruth EtzioniPeter H Gann

❮ Previous
Next ❯

Citations

Aug 9, 2007·Advances in Clinical Chemistry·M A Reymond, W Schlegel
Oct 30, 2008·Analytical and Bioanalytical Chemistry·Jon LaddShaoyi Jiang
May 31, 2006·Molecular & Cellular Proteomics : MCP·Carlos A CasianoEng M Tan
Oct 20, 2006·Critical Reviews in Clinical Laboratory Sciences·Qinghua FengNancy B Kiviat
Jul 1, 2014·Clinica Chimica Acta; International Journal of Clinical Chemistry·Xavier FilellaWladimiro Jiménez
Dec 20, 2008·Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals·Christodoulos P PipinikasChristiane D Fenske
Apr 15, 2014·The Urologic Clinics of North America·Richard J Bryant, Hans Lilja
Dec 7, 2007·Kidney International·W K HanJ V Bonventre
Nov 16, 2010·The Journal of Urology·Yuanyuan LiangIan M Thompson
Jul 28, 2009·Analytical Biochemistry·Shadab AhmadShantanu Sengupta
Aug 11, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Carsten StephanEleftherios P Diamandis
Feb 17, 2007·Cancer Letters·Mark A ReynoldsHarry Rittenhouse
Apr 6, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Catharine M Sturgeon, Andrew R Ellis
Mar 27, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Shu-Ling Liang, Daniel W Chan
Jan 30, 2007·Trends in Biotechnology·Declan A HealyRichard O'Kennedy
Apr 16, 2008·BJU International·Rituraj KonwarHemant Kumar Bid
Feb 1, 2009·Proteomics. Clinical Applications·Caroline A EvansIshtiaq Rehman
Jul 31, 2010·The Prostate·Marina RigauAndreas Doll
Feb 21, 2006·Molecular & Cellular Proteomics : MCP·Saju NettikadanEric Henderson
Jan 16, 2013·Nature Reviews. Urology·Sarah GilgunnRichard J O'Kennedy
Oct 7, 2006·Prikladnaia biokhimiia i mikrobiologiia·L I KovalevS V Mamykina
Sep 27, 2006·The American Journal of Surgical Pathology·Anil V ParwaniTheresa Y Chan
Feb 9, 2012·Nature Reviews. Urology·Hashim Uddin AhmedJeremy Kepner
Nov 13, 2019·Clinical Chemistry and Laboratory Medicine : CCLM·Michael J Duffy
Oct 11, 2014·Expert Review of Molecular Diagnostics·Daniel A McPartlin, Richard J O'Kennedy
Jan 13, 2015·Clinical Chemistry and Laboratory Medicine : CCLM·Xavier Filella, Laura Foj
Aug 11, 2019·Clinica Chimica Acta; International Journal of Clinical Chemistry·Priscila Marcelino Dos Santos SilvaMaria Tereza Dos Santos Correia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.